Skip to main content
. 2020 Mar 9;10:4307. doi: 10.1038/s41598-020-61275-w

Figure 4.

Figure 4

Schematic representation of the genome of the replication conditional, ERBB2-retargeted SurE_oHSV virus. (a) The region of the gD glycoprotein (6–38 aa) in the Survivin_oHSV backbone was substituted by a ERBB2 scFv sequence for general detargeting from cellular receptors mediating viral entry and retargeting to ERBB2+ cells. The new oncolytic virus was named SurE_oHSV (SurvivinErbb2_oncolyticHSV). (b) Replicative potential and spread (c) of double regulated SurE_oHSV were evaluated in comparison to single regulated viruses (Survivin_oHSV and R-LM113) and wild type R-LM55 virus in tumour SKOV3 and normal MRC5 cells infected with 0.03 PFU/cell. Viral genome copies were titrated 48 h post infection. Statistical significance was calculated comparing SurE_oHSV to all the other viruses (d). Cytotoxicity induced by wild type, single and double regulated viruses in normal MRC5 and tumour SKOV3 cells was evaluated according to Lactic Acid Dehydrogenase (LDH) release in cell supernatant in time course of infection from 24 to 96 hours post infection with 0.1 PFU/cell. The asterisks in the Panels b and d indicate the P values: *P < 0.05; **P < 0.005; ***P < 0.0005.